{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:21:51Z","timestamp":1790295711284,"version":"4.1.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["10083274"],"award-info":[{"award-number":["10083274"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08167-1","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:34:24Z","timestamp":1776767664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of novel reproducible combinatorial genetic risk factors for myalgic encephalomyelitis in the DecodeME patient cohort and commonalities with long COVID"],"prefix":"10.1186","volume":"24","author":[{"given":"J. M.","family":"Sardell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kolobkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Fullwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Natt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lamirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Strivens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5490-3358","authenticated-orcid":false,"given":"S.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"4","key":"8167_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: International consensus criteria. J Intern Med. 2011;270(4):327\u201338.","journal-title":"J Intern Med"},{"key":"8167_CR2","doi-asserted-by":"crossref","unstructured":"Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis\/chronic fatigue syndrome. Front Pediatr. 2019;7.","DOI":"10.3389\/fped.2019.00012"},{"issue":"3","key":"8167_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346.","journal-title":"Nat Rev Microbiol"},{"key":"8167_CR4","unstructured":"25%, ME Group. What is M.E.?. 2025. https:\/\/25megroup.org\/what-is-m-e\/."},{"issue":"1","key":"8167_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12967-025-06281-0","volume":"23","author":"M Vardaman","year":"2025","unstructured":"Vardaman M, Gilmour S, Letter. Time to correct the record on the global burden of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). J Transl Med. 2025;23(1):331.","journal-title":"J Transl Med"},{"key":"8167_CR6","unstructured":"Action For ME. Socioeconomic and healthcare impact of ME and long Covid. 2025."},{"key":"8167_CR7","unstructured":"Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/me-cfs\/about\/index.html. 2025. ME\/CFS Basics."},{"issue":"1","key":"8167_CR8","first-page":"7","volume":"57","author":"DFH Pheby","year":"2020","unstructured":"Pheby DFH, Araja D, Berkis U, Brenna E, Cullinan J, de Korwin JD, et al. A literature review of GP knowledge and understanding of ME\/CFS: A report from the socioeconomic working group of the European Network on ME\/CFS (EUROMENE). Med (B Aires). 2020;57(1):7.","journal-title":"Med (B Aires)"},{"issue":"1","key":"8167_CR9","first-page":"83","volume":"60","author":"M Thoma","year":"2023","unstructured":"Thoma M, Froehlich L, Hattesohl DBR, Quante S, Jason LA, Scheibenbogen C. Why the psychosomatic view on myalgic encephalomyelitis\/chronic fatigue syndrome is inconsistent with current evidence and harmful to patients. Med (B Aires). 2023;60(1):83.","journal-title":"Med (B Aires)"},{"issue":"2","key":"8167_CR10","first-page":"277","volume":"66","author":"AA Mirin","year":"2020","unstructured":"Mirin AA, Dimmock ME, Jason LA. Research update: The relation between ME\/CFS disease burden and research funding in the USA. Work. 2020;66(2):277\u201382.","journal-title":"Work"},{"issue":"8","key":"8167_CR11","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","volume":"30","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, et al. Long COVID science, research and policy. Nat Med. 2024;30(8):2148\u201364.","journal-title":"Nat Med"},{"key":"8167_CR12","unstructured":"World Health Organization. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition. 2022. Post COVID-19 condition (Long COVID)."},{"issue":"11","key":"8167_CR13","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/acn3.51631","volume":"9","author":"M Tziastoudi","year":"2022","unstructured":"Tziastoudi M, Cholevas C, Stefanidis I, Theoharides TC. Genetics of COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome: a systematic review. Ann Clin Transl Neurol. 2022;9(11):1838\u201357.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"8167_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00041444-200109000-00003","volume":"11","author":"CM Walsh","year":"2001","unstructured":"Walsh CM, Zainal NZ, Middleton SJ, Paykel ES. A family history study of chronic fatigue syndrome. Psychiatr Genet. 2001;11(3):123\u20138.","journal-title":"Psychiatr Genet"},{"issue":"1","key":"8167_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1300\/J092v13n01_02","volume":"13","author":"RA Underhill","year":"2006","unstructured":"Underhill RA, O\u2019Gorman R. Prevalence of Chronic Fatigue Syndrome and chronic fatigue within families of CFS patients. J Chronic Fatigue Syndr. 2006;13(1):3\u201313.","journal-title":"J Chronic Fatigue Syndr"},{"issue":"1","key":"8167_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2377-11-62","volume":"11","author":"F Albright","year":"2011","unstructured":"Albright F, Light K, Light A, Bateman L, Cannon-Albright LA. Evidence for a heritable predisposition to Chronic Fatigue Syndrome. BMC Neurol. 2011;11(1):62.","journal-title":"BMC Neurol"},{"issue":"2","key":"8167_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41588-018-0313-7","volume":"51","author":"CM Lakhani","year":"2019","unstructured":"Lakhani CM, Tierney BT, Manrai AK, Yang J, Visscher PM, Patel CJ. Repurposing large health insurance claims data to estimate genetic and environmental contributions in 560 phenotypes. Nat Genet. 2019;51(2):327\u201334.","journal-title":"Nat Genet"},{"issue":"11","key":"8167_CR18","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","volume":"50","author":"O Canela-Xandri","year":"2018","unstructured":"Canela-Xandri O, Rawlik K, Tenesa A. An atlas of genetic associations in UK Biobank. Nat Genet. 2018;50(11):1593\u20139.","journal-title":"Nat Genet"},{"issue":"9","key":"8167_CR19","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1017\/S0033291705005222","volume":"35","author":"PF Sullivan","year":"2005","unstructured":"Sullivan PF, Evengard B, Jacks A, Pedersen NL. Twin analyses of chronic fatigue in a Swedish national sample. Psychol Med. 2005;35(9):1327\u201336.","journal-title":"Psychol Med"},{"issue":"R1","key":"8167_CR20","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1093\/hmg\/ddaa169","volume":"29","author":"JJ Dibble","year":"2020","unstructured":"Dibble JJ, McGrath SJ, Ponting CP. Genetic risk factors of ME\/CFS: a critical review. Hum Mol Genet. 2020;29(R1):R117\u201324.","journal-title":"Hum Mol Genet"},{"key":"8167_CR21","doi-asserted-by":"crossref","unstructured":"Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E. Myalgic encephalomyelitis\/chronic fatigue syndrome: the biology of a neglected disease. Front Immunol. 2024;15.","DOI":"10.3389\/fimmu.2024.1386607"},{"issue":"3","key":"8167_CR22","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK Biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"1","key":"8167_CR23","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1038\/s41467-019-11953-9","volume":"10","author":"Y Tanigawa","year":"2019","unstructured":"Tanigawa Y, Li J, Justesen JM, Horn H, Aguirre M, DeBoever C, et al. Components of genetic associations across 2,138 phenotypes in the UK Biobank highlight adipocyte biology. Nat Commun. 2019;10(1):4064.","journal-title":"Nat Commun"},{"issue":"7","key":"8167_CR24","doi-asserted-by":"publisher","first-page":"e0175508","DOI":"10.1371\/journal.pone.0175508","volume":"12","author":"WQ Wei","year":"2017","unstructured":"Wei WQ, Bastarache LA, Carroll RJ, Marlo JE, Osterman TJ, Gamazon ER, et al. Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record. PLoS ONE. 2017;12(7):e0175508.","journal-title":"PLoS ONE"},{"issue":"9","key":"8167_CR25","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou W, Nielsen JB, Fritsche LG, Dey R, Gabrielsen ME, Wolford BN, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018;50(9):1335\u201341.","journal-title":"Nat Genet"},{"issue":"4","key":"8167_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000326692","volume":"64","author":"AK Smith","year":"2011","unstructured":"Smith AK, Fang H, Whistler T, Unger ER, Rajeevan MS. Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue Syndrome. Neuropsychobiology. 2011;64(4):183\u201394.","journal-title":"Neuropsychobiology"},{"issue":"2","key":"8167_CR27","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1038\/tp.2015.208","volume":"6","author":"KA Schlauch","year":"2016","unstructured":"Schlauch KA, Khaiboullina SF, De Meirleir KL, Rawat S, Petereit J, Rizvanov AA, et al. Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis\/chronic fatigue syndrome. Transl Psychiatry. 2016;6(2):e730\u2013730.","journal-title":"Transl Psychiatry"},{"issue":"12","key":"8167_CR28","doi-asserted-by":"publisher","first-page":"e1007309","DOI":"10.1371\/journal.pgen.1007309","volume":"14","author":"JH Sul","year":"2018","unstructured":"Sul JH, Martin LS, Eskin E. Population structure in genetic studies: Confounding factors and mixed models. PLoS Genet. 2018;14(12):e1007309.","journal-title":"PLoS Genet"},{"issue":"1","key":"8167_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12883-022-02763-6","volume":"22","author":"A Devereux-Cooke","year":"2022","unstructured":"Devereux-Cooke A, Leary S, McGrath SJ, Northwood E, Redshaw A, Shepherd C, et al. DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis \/ chronic fatigue syndrome. BMC Neurol. 2022;22(1):269.","journal-title":"BMC Neurol"},{"key":"8167_CR30","unstructured":"DecodeME. Initial findings from the DecodeME genome-wide association study of myalgic encephalomyelitis\/chronic fatigue syndrome. medRxiv. 2025."},{"key":"8167_CR31","first-page":"100003","volume":"1","author":"S Gardner","year":"2021","unstructured":"Gardner S. Combinatorial analytics: An essential tool for the delivery of precision medicine and precision agriculture. Artif Intell Life Sci. 2021;1:100003.","journal-title":"Artif Intell Life Sci"},{"issue":"1","key":"8167_CR32","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1186\/s12967-022-03815-8","volume":"20","author":"S Das","year":"2022","unstructured":"Das S, Taylor K, Kozubek J, Sardell J, Gardner S. Genetic risk factors for ME\/CFS identified using combinatorial analysis. J Transl Med. 2022;20(1):598.","journal-title":"J Transl Med"},{"key":"8167_CR33","doi-asserted-by":"crossref","unstructured":"Sardell J, Das S, M\u00f8ller G, Sanna M, Chocian K, Taylor K et al. Identification and validation of novel combinatorial genetic risk factors for endometriosis across multiple UK and US patient cohorts. medRxiv. 2025.","DOI":"10.1101\/2025.08.13.25333595"},{"key":"8167_CR34","doi-asserted-by":"crossref","unstructured":"Das S, Pearson M, Taylor K, Bouchet V, M\u00f8ller GL, Hall TO, et al. Combinatorial analysis of phenotypic and clinical risk factors associated with hospitalized COVID-19 patients. Front Digit Health. 2021;3.","DOI":"10.3389\/fdgth.2021.660809"},{"issue":"1","key":"8167_CR35","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1186\/s12967-023-04588-4","volume":"21","author":"K Taylor","year":"2023","unstructured":"Taylor K, Pearson M, Das S, Sardell J, Chocian K, Gardner S. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME\/CFS identified by combinatorial analysis. J Transl Med. 2023;21(1):775.","journal-title":"J Transl Med"},{"issue":"1","key":"8167_CR36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-025-06535-x","volume":"23","author":"J Sardell","year":"2025","unstructured":"Sardell J, Pearson M, Chocian K, Das S, Taylor K, Strivens M, et al. Reproducibility of genetic risk factors identified for long COVID using combinatorial analysis across US and UK patient cohorts with diverse ancestries. J Transl Med. 2025;23(1):516.","journal-title":"J Transl Med"},{"key":"8167_CR37","first-page":"100125","volume":"7","author":"J Sardell","year":"2025","unstructured":"Sardell J, Das S, Taylor K, Stubberfield C, Malinowski A, Strivens M, et al. Actively protective combinatorial analysis: A scalable novel method for detecting variants that contribute to reduced disease prevalence in high-risk individuals. Artif Intell Life Sci. 2025;7:100125.","journal-title":"Artif Intell Life Sci"},{"key":"8167_CR38","doi-asserted-by":"publisher","unstructured":"Komaroff AL, Lipkin WI. ME\/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne). 2023 Jun 2;10:1187163 . https:\/\/doi.org\/10.3389\/fmed.2023.1187163","DOI":"10.3389\/fmed.2023.1187163"},{"key":"8167_CR39","doi-asserted-by":"crossref","unstructured":"Eckey M, Li P, Morrison B, Bergquist J, Davis RW, Xiao W. Patient-reported treatment outcomes in ME\/CFS and long COVID. Proceedings of the National Academy of Sciences. 2025;122(28).","DOI":"10.1073\/pnas.2426874122"},{"key":"8167_CR40","doi-asserted-by":"crossref","unstructured":"Shankar V, Wilhelmy J, Curtis EJ, Michael B, Cervantes L, Mallajosyula V, et al. Oxidative stress is a shared characteristic of ME\/CFS and Long COVID. Proceedings of the National Academy of Sciences. 2025;122(28).","DOI":"10.1073\/pnas.2426564122"},{"key":"8167_CR41","doi-asserted-by":"crossref","unstructured":"Cheng Z. Integrative genome-wide association studies of COVID-19 susceptibility and hospitalization reveal risk loci for long COVID. medRxiv. 2025.","DOI":"10.21203\/rs.3.rs-5807438\/v1"},{"key":"8167_CR42","doi-asserted-by":"crossref","unstructured":"Marees AT, de Kluiver H, Stringer S, Vorspan F, Curis E, Marie-Claire C, et al. A tutorial on conducting genome\u2010wide association studies: quality control and statistical analysis. Int J Methods Psychiatr Res. 2018;27(2).","DOI":"10.1002\/mpr.1608"},{"issue":"8","key":"8167_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/gepi.20639","volume":"35","author":"RL Zuvich","year":"2011","unstructured":"Zuvich RL, Armstrong LL, Bielinski SJ, Bradford Y, Carlson CS, Crawford DC, et al. Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data quality. Genet Epidemiol. 2011;35(8):887\u201398.","journal-title":"Genet Epidemiol"},{"issue":"1","key":"8167_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00439-011-1054-1","volume":"131","author":"JA Sinnott","year":"2012","unstructured":"Sinnott JA, Kraft P. Artifact due to differential error when cases and controls are imputed from different platforms. Hum Genet. 2012;131(1):111\u20139.","journal-title":"Hum Genet"},{"issue":"1","key":"8167_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12859-017-1756-z","volume":"18","author":"JA Tom","year":"2017","unstructured":"Tom JA, Reeder J, Forrest WF, Graham RR, Hunkapiller J, Behrens TW, et al. Identifying and mitigating batch effects in whole genome sequencing data. BMC Bioinformatics. 2017;18(1):351.","journal-title":"BMC Bioinformatics"},{"issue":"22","key":"8167_CR46","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1093\/bioinformatics\/btt480","volume":"29","author":"SE Reese","year":"2013","unstructured":"Reese SE, Archer KJ, Therneau TM, Atkinson EJ, Vachon CM, de Andrade M, et al. A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis. Bioinformatics. 2013;29(22):2877\u201383.","journal-title":"Bioinformatics"},{"key":"8167_CR47","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences. 2005;102(43):15545\u201350.","DOI":"10.1073\/pnas.0506580102"},{"key":"8167_CR48","unstructured":"Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, Ebert D, et al. The gene ontology knowledgebase in 2023. Genetics. 2023;224(1)."},{"issue":"D1","key":"8167_CR49","doi-asserted-by":"publisher","first-page":"D679","DOI":"10.1093\/nar\/gkad960","volume":"52","author":"A Agrawal","year":"2024","unstructured":"Agrawal A, Balc\u0131 H, Hanspers K, Coort SL, Martens M, Slenter DN, et al. WikiPathways 2024: next generation pathway database. Nucleic Acids Res. 2024;52(D1):D679\u201389.","journal-title":"Nucleic Acids Res"},{"key":"8167_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbi.2021.08.219","volume":"98","author":"R Hajdarevic","year":"2021","unstructured":"Hajdarevic R, Lande A, Rekeland I, Rydland A, Strand EB, Sosa DD, et al. Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) suggests involvement of both HLA class I and class II loci. Brain Behav Immun. 2021;98:101\u20139.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"8167_CR51","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/s41598-020-62157-x","volume":"10","author":"A Lande","year":"2020","unstructured":"Lande A, Fluge \u00d8, Strand EB, Fl\u00e5m ST, Sosa DD, Mella O, et al. Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). Sci Rep. 2020;10(1):5267.","journal-title":"Sci Rep"},{"issue":"1","key":"8167_CR52","doi-asserted-by":"publisher","first-page":"37303","DOI":"10.1038\/s41598-025-21230-z","volume":"15","author":"AP Georgopoulos","year":"2025","unstructured":"Georgopoulos AP, James LM, Peterson PK. HLA and pathogens in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and other post-infection conditions. Sci Rep. 2025;15(1):37303.","journal-title":"Sci Rep"},{"issue":"4","key":"8167_CR53","doi-asserted-by":"publisher","first-page":"105057","DOI":"10.1016\/j.idnow.2025.105057","volume":"55","author":"E Pons-Fuster","year":"2025","unstructured":"Pons-Fuster E, Martinez-Rodriguez R, Gimeno-Arias L, Alcaraz MJ, Moreno M, G\u00f3mez JM, et al. HLA-A*03 may confer protection against long COVID through an enhanced immune response. Infect Dis Now. 2025;55(4):105057.","journal-title":"Infect Dis Now"},{"issue":"1","key":"8167_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29245\/2578-3009\/2025\/1.1257","volume":"9","author":"A Georgopoulos","year":"2025","unstructured":"Georgopoulos A, James L, Peterson P. Human Leukocyte Antigen (HLA) at the root of persistent antigens and Long COVID. J Immunol Sci. 2025;9(1):1\u20133.","journal-title":"J Immunol Sci"},{"issue":"5","key":"8167_CR55","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.molmed.2024.02.003","volume":"30","author":"SJ Annesley","year":"2024","unstructured":"Annesley SJ, Missailidis D, Heng B, Josev EK, Armstrong CW. Unravelling shared mechanisms: insights from recent ME\/CFS research to illuminate long COVID pathologies. Trends Mol Med. 2024;30(5):443\u201358.","journal-title":"Trends Mol Med"},{"issue":"1","key":"8167_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12967-023-04808-x","volume":"22","author":"JS Lee","year":"2024","unstructured":"Lee JS, Kang JY, Park SY, Hwang SJ, Bae SJ, Son CG. Central 5-HTergic hyperactivity induces myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)-like pathophysiology. J Transl Med. 2024;22(1):34.","journal-title":"J Transl Med"},{"key":"8167_CR57","doi-asserted-by":"crossref","unstructured":"Hendrix J, Fanning L, Wyns A, Ahmed I, Patil MS, Richter E, et al. Adrenergic dysfunction in patients with myalgic encephalomyelitis\/chronic fatigue syndrome and fibromyalgia: a systematic review and meta-analysis. Eur J Clin Invest. 2025;55(1).","DOI":"10.1111\/eci.14318"},{"issue":"3","key":"8167_CR58","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s12311-010-0182-9","volume":"11","author":"A Kasumu","year":"2012","unstructured":"Kasumu A, Bezprozvanny I. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias. Cerebellum. 2012;11(3):630\u20139.","journal-title":"Cerebellum"},{"issue":"7","key":"8167_CR59","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/biom13071039","volume":"13","author":"S Du Preez","year":"2023","unstructured":"Du Preez S, Eaton-Fitch N, Smith PK, Marshall-Gradisnik S. Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Patients. Biomolecules. 2023;13(7):1039.","journal-title":"Biomolecules"},{"issue":"10","key":"8167_CR60","doi-asserted-by":"publisher","first-page":"e0240403","DOI":"10.1371\/journal.pone.0240403","volume":"15","author":"DR Strayer","year":"2020","unstructured":"Strayer DR, Young D, Mitchell WM. Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. PLoS ONE. 2020;15(10):e0240403.","journal-title":"PLoS ONE"},{"issue":"2","key":"8167_CR61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","volume":"103","author":"RJ Davis","year":"2000","unstructured":"Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103(2):239\u201352.","journal-title":"Cell"},{"key":"8167_CR62","doi-asserted-by":"publisher","first-page":"877772","DOI":"10.3389\/fneur.2022.877772","volume":"13","author":"W Tate","year":"2022","unstructured":"Tate W, Walker M, Sweetman E, Helliwell A, Peppercorn K, Edgar C, et al. Molecular mechanisms of neuroinflammation in ME\/CFS and long COVID to sustain disease and promote relapses. Front Neurol. 2022;13:877772.","journal-title":"Front Neurol"},{"key":"8167_CR63","doi-asserted-by":"publisher","first-page":"952987","DOI":"10.3389\/fimmu.2022.952987","volume":"13","author":"Y Lv","year":"2022","unstructured":"Lv Y, Zhang T, Cai J, Huang C, Zhan S, Liu J. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Front Immunol. 2022;13:952987.","journal-title":"Front Immunol"},{"key":"8167_CR64","doi-asserted-by":"crossref","unstructured":"George PM, Reed A, Desai SR, Devaraj A, Faiez TS, Laverty S, et al. A persistent neutrophil-associated immune signature characterizes post\u2013COVID-19 pulmonary sequelae. Sci Transl Med. 2022;14(671).","DOI":"10.1126\/scitranslmed.abo5795"},{"issue":"1","key":"8167_CR65","doi-asserted-by":"publisher","first-page":"22068","DOI":"10.1038\/s41598-023-49402-9","volume":"13","author":"K Peppercorn","year":"2023","unstructured":"Peppercorn K, Edgar CD, Kleffmann T, Tate WP. A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis\/chronic fatigue syndrome. Sci Rep. 2023;13(1):22068.","journal-title":"Sci Rep"},{"issue":"12","key":"8167_CR66","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nrn3392","volume":"13","author":"L Welberg","year":"2012","unstructured":"Welberg L. Neuroligin 1 does the splits. Nat Rev Neurosci. 2012;13(12):811\u2013811.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"8167_CR67","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/0748730418761236","volume":"33","author":"L Hannou","year":"2018","unstructured":"Hannou L, B\u00e9langer-Nelson E, O\u2019Callaghan EK, Dufort-Gervais J, Ballester Roig MN, Roy PG, et al. Regulation of the Neuroligin-1 gene by Clock transcription factors. J Biol Rhythms. 2018;33(2):166\u201378.","journal-title":"J Biol Rhythms"},{"key":"8167_CR68","doi-asserted-by":"publisher","unstructured":"Zhang S, Jahanbani F, Chander V, Kjellberg M, Liu M, Glass KA, et al. Dissecting the genetic complexity of myalgic encephalomyelitis\/chronic fatigue syndrome via deep learning-powered genome analysis. medRxiv [Preprint]. 2025 May 11:2025.04.15.25325899. https:\/\/doi.org\/10.1101\/2025.04.15.25325899","DOI":"10.1101\/2025.04.15.25325899"},{"issue":"1","key":"8167_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-021-01119-4","volume":"9","author":"E Camporesi","year":"2021","unstructured":"Camporesi E, Lashley T, Gobom J, Lantero-Rodriguez J, Hansson O, Zetterberg H, et al. Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers. Acta Neuropathol Commun. 2021;9(1):19.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"8167_CR70","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/nyas.14002","volume":"1451","author":"GR Uhl","year":"2019","unstructured":"Uhl GR, Martinez MJ. PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes. Ann N Y Acad Sci. 2019;1451(1):112\u201329.","journal-title":"Ann N Y Acad Sci"},{"key":"8167_CR71","doi-asserted-by":"crossref","unstructured":"Arcos-Burgos M, Arcos-Holzinger M, Mastronardi C, Isaza-Ruget MA, V\u00e9lez JI, Lewis DP, et al. Neurodevelopment genes encoding Olduvai domains link myalgic encephalomyelitis to neuropsychiatric disorders. Diagnostics (Basel). 2025;15(12).","DOI":"10.3390\/diagnostics15121542"},{"issue":"6","key":"8167_CR72","doi-asserted-by":"publisher","first-page":"100496","DOI":"10.1016\/j.patter.2022.100496","volume":"3","author":"S Das","year":"2022","unstructured":"Das S, Taylor K, Beaulah S, Gardner S. Systematic indication extension for drugs using patient stratification insights generated by combinatorial analytics. Patterns. 2022;3(6):100496.","journal-title":"Patterns"},{"issue":"3","key":"8167_CR73","doi-asserted-by":"publisher","first-page":"e31334","DOI":"10.1371\/journal.pone.0031334","volume":"7","author":"DR Strayer","year":"2012","unstructured":"Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, et al. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS ONE. 2012;7(3):e31334.","journal-title":"PLoS ONE"},{"issue":"6","key":"8167_CR74","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1586\/17512433.2016.1172960","volume":"9","author":"WM Mitchell","year":"2016","unstructured":"Mitchell WM. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). Expert Rev Clin Pharmacol. 2016;9(6):755\u201370.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"8167_CR75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/CMR.00022-07","volume":"21","author":"E Vercammen","year":"2008","unstructured":"Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev. 2008;21(1):13\u201325.","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"8167_CR76","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1084\/jem.20081370","volume":"205","author":"KA Cavassani","year":"2008","unstructured":"Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med. 2008;205(11):2609\u201321.","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"8167_CR77","doi-asserted-by":"publisher","first-page":"605","DOI":"10.15171\/apb.2015.082","volume":"5","author":"A Mohammad Hosseini","year":"2015","unstructured":"Mohammad Hosseini A, Majidi J, Baradaran B, Yousefi M. Toll-like receptors in the pathogenesis of autoimmune diseases. Adv Pharm Bull. 2015;5(Suppl 1):605\u201314.","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"8167_CR78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40364-025-00739-5","volume":"13","author":"ML Hsieh","year":"2025","unstructured":"Hsieh ML, Nishizaki D, Adashek JJ, Kato S, Kurzrock R. Toll-like receptor 3: a double-edged sword. Biomark Res. 2025;13(1):32.","journal-title":"Biomark Res"},{"issue":"5","key":"8167_CR79","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/cells9051254","volume":"9","author":"AJ Tibbo","year":"2020","unstructured":"Tibbo AJ, Baillie GS. Phosphodiesterase 4B: Master regulator of brain signaling. Cells. 2020;9(5):1254.","journal-title":"Cells"},{"key":"8167_CR80","doi-asserted-by":"crossref","unstructured":"Su Y, Ding J, Yang F, He C, Xu Y, Zhu X, et al. The regulatory role of PDE4B in the progression of inflammatory function study. Front Pharmacol. 2022;13.","DOI":"10.3389\/fphar.2022.982130"},{"key":"8167_CR81","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.neuropharm.2017.08.011","volume":"125","author":"DV Avila","year":"2017","unstructured":"Avila DV, Myers SA, Zhang J, Kharebava G, McClain CJ, Kim HY, et al. Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation. Neuropharmacology. 2017;125:376\u201385.","journal-title":"Neuropharmacology"},{"key":"8167_CR82","doi-asserted-by":"crossref","unstructured":"Jin SLC, Conti M. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-\u03b1 responses. Proceedings of the National Academy of Sciences. 2002;99(11):7628\u201333.","DOI":"10.1073\/pnas.122041599"},{"key":"8167_CR83","doi-asserted-by":"crossref","unstructured":"Li H, Zuo J, Tang W. Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases. Front Pharmacol. 2018;9.","DOI":"10.3389\/fphar.2018.01048"},{"key":"8167_CR84","doi-asserted-by":"publisher","first-page":"105078","DOI":"10.1016\/j.phrs.2020.105078","volume":"160","author":"A Bhat","year":"2020","unstructured":"Bhat A, Ray B, Mahalakshmi AM, Tuladhar S, Nandakumar D, Srinivasan M, et al. Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders. Pharmacol Res. 2020;160:105078.","journal-title":"Pharmacol Res"},{"issue":"7","key":"8167_CR85","doi-asserted-by":"publisher","first-page":"e70030","DOI":"10.1002\/ardp.70030","volume":"358","author":"V Ks","year":"2025","unstructured":"Ks V, Akkewar AS, Murtikumar MN, Sethi KK. PDE4B inhibition: Exploring the landscape of chemistry behind specific PDE4B inhibitors, drug design, and discovery. Arch Pharm (Weinheim). 2025;358(7):e70030.","journal-title":"Arch Pharm (Weinheim)"},{"key":"8167_CR86","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1101\/lm.054101.125","volume":"32","author":"H Zhao","year":"2025","unstructured":"Zhao H, Blokland A, Prickaerts J, Havekes R, Meijer EL, Heckman PRA. Individual contribution of PDE4B and PDE4D subfamilies to the prevention of object location memory impairments induced by sleep deprivation. Learn Mem. 2025;32:5\u20136.","journal-title":"Learn Mem"},{"issue":"Supplement2","key":"8167_CR87","first-page":"638","volume":"28","author":"S Kida","year":"2025","unstructured":"Kida S. Memory modulation by dopamine-cAMP signal transduction pathways. Int J Neuropsychopharmacol. 2025;28(Supplement2):638.","journal-title":"Int J Neuropsychopharmacol"},{"key":"8167_CR88","doi-asserted-by":"crossref","unstructured":"Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, et al. Estimating prevalence, demographics, and costs of ME\/CFS using large scale medical claims data and machine learning. Front Pediatr. 2019;6.","DOI":"10.3389\/fped.2018.00412"},{"key":"8167_CR89","doi-asserted-by":"crossref","unstructured":"Dai J, He F, Chen Q, Li Q, Zhao L, Du Y. Animal models of post-acute COVID-19 syndrome: a call for longitudinal animal studies. Front Immunol. 2025;16.","DOI":"10.3389\/fimmu.2025.1521029"},{"key":"8167_CR90","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Gonz\u00e1lez L, Mart\u00ed-Sarrias A, Puertas MC, Bay\u00f3n-Gil \u00c1, Resa-Infante P, Martinez-Picado J, et al. Understanding the neurological implications of acute and long COVID using brain organoids. Dis Model Mech. 2023;16(7).","DOI":"10.1242\/dmm.050049"},{"issue":"1","key":"8167_CR91","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","volume":"1","author":"E Uffelmann","year":"2021","unstructured":"Uffelmann E, Huang QQ, Munung NS, de Vries J, Okada Y, Martin AR, et al. Genome-wide association studies. Nat Reviews Methods Primers. 2021;1(1):59.","journal-title":"Nat Reviews Methods Primers"},{"issue":"8","key":"8167_CR92","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","volume":"20","author":"V Tam","year":"2019","unstructured":"Tam V, Patel N, Turcotte M, Boss\u00e9 Y, Par\u00e9 G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20(8):467\u201384.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"8167_CR93","doi-asserted-by":"publisher","first-page":"e094658","DOI":"10.1136\/bmjopen-2024-094658","volume":"15","author":"M Mansoubi","year":"2025","unstructured":"Mansoubi M, Richards T, Ainsworth-Wells M, Fleming R, Leveridge P, Shepherd C, et al. Understanding symptom clusters, diagnosis and healthcare experiences in myalgic encephalomyelitis\/chronic fatigue syndrome and long COVID: a cross-sectional survey in the UK. BMJ Open. 2025;15(4):e094658.","journal-title":"BMJ Open"},{"issue":"1","key":"8167_CR94","doi-asserted-by":"publisher","first-page":"10326","DOI":"10.1038\/s41467-025-65302-0","volume":"16","author":"R Green","year":"2025","unstructured":"Green R, Marjenberg Z, Lip GYH, Banerjee A, Wisnivesky J, Delaney BC, et al. A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID. Nat Commun. 2025;16(1):10326.","journal-title":"Nat Commun"},{"issue":"7","key":"8167_CR95","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1473-3099(23)00287-6","volume":"23","author":"Z Al-Aly","year":"2023","unstructured":"Al-Aly Z. Prevention of long COVID: progress and challenges. Lancet Infect Dis. 2023;23(7):776\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"8167_CR96","doi-asserted-by":"publisher","first-page":"106190","DOI":"10.1016\/j.jinf.2024.106190","volume":"89","author":"J Jiang","year":"2024","unstructured":"Jiang J, Li Y, Jiang Q, Jiang Y, Qin H, Li Y. Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: A systematic review and network meta-analysis. J Infect. 2024;89(2):106190.","journal-title":"J Infect"},{"issue":"1","key":"8167_CR97","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12967-023-04229-w","volume":"21","author":"A Ghali","year":"2023","unstructured":"Ghali A, Lacombe V, Ravaiau C, Delattre E, Ghali M, Urbanski G, et al. The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome. J Transl Med. 2023;21(1):375.","journal-title":"J Transl Med"},{"key":"8167_CR98","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3310\/nihropenres.13421.2","volume":"3","author":"AD Bretherick","year":"2023","unstructured":"Bretherick AD, McGrath SJ, Devereux-Cooke A, Leary S, Northwood E, Redshaw A, et al. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study. NIHR Open Res. 2023;3:20.","journal-title":"NIHR Open Res"},{"issue":"8","key":"8167_CR99","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","volume":"30","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, et al. Long COVID science, research and policy. Nat Med. 2024;30(8):2148\u201364.","journal-title":"Nat Med"},{"key":"8167_CR100","unstructured":"Open Medicine Foundation. The LIFT Improvement Trial (LIFT). 2025. https:\/\/www.omf.ngo\/the-life-improvement-trial\/."},{"key":"8167_CR101","unstructured":"National Library of Medicine. LIFT: Life Improvement Trial, ClincalTrials.gov ID NCT06366724. 2025. https:\/\/www.clinicaltrials.gov\/study\/NCT06366724."},{"issue":"1","key":"8167_CR102","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1186\/s12967-025-07213-8","volume":"23","author":"BT Ruan","year":"2025","unstructured":"Ruan BT, Bulbule S, Gile B, Reyes A, Chheda B, Bateman L, et al. Low-dose rapamycin alleviates clinical symptoms of fatigue and PEM in ME\/CFS patients via improvement of autophagy: a pilot study. J Transl Med. 2025;23(1):1148.","journal-title":"J Transl Med"},{"key":"8167_CR103","unstructured":"Open Medicine Foundation Canada. ME\/CFS Adaptive Therapeutic Solution Platform (MEDUSA) - Phase 1. 2025. https:\/\/www.omfcanada.ngo\/mecfs-adaptive-therapeutic-solution-platform\/."},{"key":"8167_CR104","unstructured":"Walrath. Rowan. Long COVID studies stymied by pharma\u2019s lack of cooperation. Chemical & Engineering News; 2025."},{"issue":"2","key":"8167_CR105","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","volume":"27","author":"K Park","year":"2019","unstructured":"Park K. A review of computational drug repurposing. Transl Clin Pharmacol. 2019;27(2):59.","journal-title":"Transl Clin Pharmacol"},{"issue":"1","key":"8167_CR106","doi-asserted-by":"publisher","first-page":"19","DOI":"10.6030\/1939-067X-3.1.19","volume":"3","author":"SR Evans","year":"2010","unstructured":"Evans SR. Fundamentals of clinical trial design. J Exp Stroke Transl Med. 2010;3(1):19\u201327.","journal-title":"J Exp Stroke Transl Med"},{"issue":"1","key":"8167_CR107","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12967-019-02196-9","volume":"18","author":"DY Kim","year":"2020","unstructured":"Kim DY, Lee JS, Park SY, Kim SJ, Son CG. Systematic review of randomized controlled trials for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). J Transl Med. 2020;18(1):7.","journal-title":"J Transl Med"},{"key":"8167_CR108","doi-asserted-by":"crossref","unstructured":"Eckey M, Li P, Morrison B, Bergquist J, Davis RW, Xiao W. Patient-reported treatment outcomes in ME\/CFS and long COVID. Proceedings of the National Academy of Sciences. 2025;122(28).","DOI":"10.1073\/pnas.2426874122"},{"issue":"7","key":"8167_CR109","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","volume":"169","author":"EA Boyle","year":"2017","unstructured":"Boyle EA, Li YI, Pritchard JK. An expanded view of complex traits: From polygenic to omnigenic. Cell. 2017;169(7):1177\u201386.","journal-title":"Cell"},{"key":"8167_CR110","doi-asserted-by":"crossref","unstructured":"Ru\u017ei\u010dkov\u00e1 N, Hled\u00edk M, Tka\u010dik G. Quantitative omnigenic model discovers interpretable genome-wide associations. Proceedings of the National Academy of Sciences. 2024;121(44).","DOI":"10.1073\/pnas.2402340121"},{"issue":"9","key":"8167_CR111","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.ajhg.2025.07.006","volume":"112","author":"F Ratajczak","year":"2025","unstructured":"Ratajczak F, Heinig M, Falter-Braun P. Exploring the omnigenic architecture of selected complex traits. Am J Hum Genet. 2025;112(9):2115\u201337.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"8167_CR112","doi-asserted-by":"publisher","first-page":"e1008903","DOI":"10.1371\/journal.pgen.1008903","volume":"16","author":"A Ratnakumar","year":"2020","unstructured":"Ratnakumar A, Weinhold N, Mar JC, Riaz N. Protein-Protein interactions uncover candidate \u2018core genes\u2019 within omnigenic disease networks. PLoS Genet. 2020;16(7):e1008903.","journal-title":"PLoS Genet"},{"issue":"7","key":"8167_CR113","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.cell.2018.05.051","volume":"173","author":"NR Wray","year":"2018","unstructured":"Wray NR, Wijmenga C, Sullivan PF, Yang J, Visscher PM. Common disease is more complex than implied by the core gene omnigenic model. Cell. 2018;173(7):1573\u201380.","journal-title":"Cell"},{"issue":"1","key":"8167_CR114","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12967-025-07506-y","volume":"24","author":"J Fan","year":"2025","unstructured":"Fan J, Jiao J, Chang HQ, Zhong DL, Liu XB, Li J, et al. Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): diagnosis and management. J Transl Med. 2025;24(1):62.","journal-title":"J Transl Med"},{"issue":"22","key":"8167_CR115","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.3390\/ijms232213771","volume":"23","author":"V Scalavino","year":"2022","unstructured":"Scalavino V, Piccinno E, Valentini A, Mastronardi M, Armentano R, Giannelli G, et al. A novel mechanism of immunoproteasome regulation via miR-369-3p in intestinal inflammatory response. Int J Mol Sci. 2022;23(22):13771.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"8167_CR116","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3390\/cells9081910","volume":"9","author":"HS Teixeira","year":"2020","unstructured":"Teixeira HS, Zhao J, Kazmierski E, Kinane DF, Benakanakere MR. TLR3-dependent activation of TLR2 endogenous ligands via the MyD88 signaling pathway augments the innate immune response. Cells. 2020;9(8):1910.","journal-title":"Cells"},{"issue":"4","key":"8167_CR117","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000322375","volume":"3","author":"N Kawasaki","year":"2011","unstructured":"Kawasaki N, Rademacher C, Paulson JC. CD22 regulates adaptive and innate immune responses of B cells. J Innate Immun. 2011;3(4):411\u20139.","journal-title":"J Innate Immun"},{"issue":"10","key":"8167_CR118","doi-asserted-by":"publisher","first-page":"e1006618","DOI":"10.1371\/journal.ppat.1006618","volume":"13","author":"SA Condotta","year":"2017","unstructured":"Condotta SA, Richer MJ. The immune battlefield: The impact of inflammatory cytokines on CD8\u2009+\u2009T-cell immunity. PLoS Pathog. 2017;13(10):e1006618.","journal-title":"PLoS Pathog"},{"issue":"12","key":"8167_CR119","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.4049\/jimmunol.1202574","volume":"190","author":"CS Yang","year":"2013","unstructured":"Yang CS, Kim JJ, Lee SJ, Hwang JH, Lee CH, Lee MS, et al. TLR3-triggered reactive oxygen species contribute to inflammatory responses by activating signal transducer and activator of transcription-1. J Immunol. 2013;190(12):6368\u201377.","journal-title":"J Immunol"},{"key":"8167_CR120","doi-asserted-by":"crossref","unstructured":"Iu DS, Maya J, Vu LT, Fogarty EA, McNairn AJ, Ahmed F, et al. Transcriptional reprogramming primes CD8\u2009+\u2009T cells toward exhaustion in Myalgic encephalomyelitis\/chronic fatigue syndrome. Proceedings of the National Academy of Sciences. 2024;121(50).","DOI":"10.1073\/pnas.2415119121"},{"issue":"1","key":"8167_CR121","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1038\/s41467-023-39642-8","volume":"14","author":"M Kim","year":"2023","unstructured":"Kim M, Serwa RA, Samluk L, Suppanz I, Kodro\u0144 A, St\u0119pkowski TM, et al. Immunoproteasome-specific subunit PSMB9 induction is required to regulate cellular proteostasis upon mitochondrial dysfunction. Nat Commun. 2023;14(1):4092.","journal-title":"Nat Commun"},{"issue":"1","key":"8167_CR122","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/CIRCRESAHA.122.322360","volume":"134","author":"S Li","year":"2024","unstructured":"Li S, He RC, Wu SG, Song Y, Zhang KL, Tang ML, et al. LncRNA PSMB8-AS1 Instigates Vascular Inflammation to Aggravate Atherosclerosis. Circ Res. 2024;134(1):60\u201380.","journal-title":"Circ Res"},{"key":"8167_CR123","doi-asserted-by":"crossref","unstructured":"Kukan EN, Fabiano GL, Zhou JY, Richard AR, Telfer KA, Cobb BA. Ablation of CD22 induces a pro-inflammatory transcriptome shift and endocytic deficits in M2-like macrophages. Glycobiology. 2025;35(11).","DOI":"10.1093\/glycob\/cwaf076"},{"key":"8167_CR124","doi-asserted-by":"crossref","unstructured":"Alves-Filho JC, P\u00e5lsson-McDermott EM. Pyruvate kinase M2: a potential target for regulating inflammation. Front Immunol. 2016;7.","DOI":"10.3389\/fimmu.2016.00145"},{"issue":"10","key":"8167_CR125","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.2337\/db21-0028","volume":"70","author":"G Farias Quipildor","year":"2021","unstructured":"Farias Quipildor G, Mao K, Beltran PJ, Barzilai N, Huffman DM. Modulation of glucose production by central insulin requires IGF-1 receptors in AgRP neurons. Diabetes. 2021;70(10):2237\u201349.","journal-title":"Diabetes"},{"issue":"1","key":"8167_CR126","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molcel.2017.05.020","volume":"67","author":"S Roy","year":"2017","unstructured":"Roy S, Leidal AM, Ye J, Ronen SM, Debnath J. Autophagy-dependent shuttling of TBC1D5 controls plasma membrane translocation of GLUT1 and glucose uptake. Mol Cell. 2017;67(1):84\u2013e955.","journal-title":"Mol Cell"},{"issue":"3","key":"8167_CR127","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1194\/jlr.M045294","volume":"55","author":"W de Haan","year":"2014","unstructured":"de Haan W, Bhattacharjee A, Ruddle P, Kang MH, Hayden MR. ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity. J Lipid Res. 2014;55(3):516\u201323.","journal-title":"J Lipid Res"},{"issue":"1","key":"8167_CR128","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-018-06406-8","volume":"9","author":"OA Stone","year":"2018","unstructured":"Stone OA, El-Brolosy M, Wilhelm K, Liu X, Rom\u00e3o AM, Grillo E, et al. Loss of pyruvate kinase M2 limits growth and triggers innate immune signaling in endothelial cells. Nat Commun. 2018;9(1):4077.","journal-title":"Nat Commun"},{"issue":"1","key":"8167_CR129","doi-asserted-by":"publisher","first-page":"13280","DOI":"10.1038\/ncomms13280","volume":"7","author":"M Xie","year":"2016","unstructured":"Xie M, Yu Y, Kang R, Zhu S, Yang L, Zeng L, et al. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nat Commun. 2016;7(1):13280.","journal-title":"Nat Commun"},{"issue":"15","key":"8167_CR130","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.3390\/cancers13153850","volume":"13","author":"H Koo","year":"2021","unstructured":"Koo H, Byun S, Seo J, Jung Y, Lee DC, Cho JH, et al. PKM2 regulates HSP90-mediated stability of the IGF-1R precursor protein and promotes cancer cell durvival during hypoxia. Cancers (Basel). 2021;13(15):3850.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"8167_CR131","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1080\/15384101.2015.1026490","volume":"14","author":"B Salani","year":"2015","unstructured":"Salani B, Ravera S, Amaro A, Salis A, Passalacqua M, Millo E, et al. IGF1 regulates PKM2 function through Akt phosphorylation. Cell Cycle. 2015;14(10):1559\u201367.","journal-title":"Cell Cycle"},{"issue":"36","key":"8167_CR132","doi-asserted-by":"publisher","first-page":"9731","DOI":"10.1073\/pnas.1617876114","volume":"114","author":"R Cintron-Colon","year":"2017","unstructured":"Cintron-Colon R, Sanchez-Alavez M, Nguyen W, Mori S, Gonzalez-Rivera R, Lien T, et al. Insulin-like growth factor 1 receptor regulates hypothermia during calorie restriction. Proc Natl Acad Sci. 2017;114(36):9731\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"8167_CR133","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1210\/en.2017-00261","volume":"158","author":"JC Fran\u00e7ois","year":"2017","unstructured":"Fran\u00e7ois JC, A\u00efd S, Chaker Z, Lacube P, Xu J, Fayad R, et al. Disrupting IGF signaling in adult mice conditions leanness, resilient energy metabolism, and high growth hormone pulses. Endocrinology. 2017;158(7):2269\u201383.","journal-title":"Endocrinology"},{"key":"8167_CR134","unstructured":"Applied Biosystems. UK Biobank Axiom Array data sheet. 2017. https:\/\/www.bioresource.nihr.ac.uk\/media\/nlybpdcd\/uk_axiom_biobank_genotyping_arrays_datasheet.pdf."},{"issue":"9","key":"8167_CR135","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ajhg.2021.07.003","volume":"108","author":"I Mathieson","year":"2021","unstructured":"Mathieson I. The omnigenic model and polygenic prediction of complex traits. Am J Hum Genet. 2021;108(9):1558\u201363.","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08167-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:02:47Z","timestamp":1780549367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08167-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8167"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08167-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research described in this article has been conducted using data from DecodeME study and UK Biobank (application number 44288). Consent to participate has been received from all participants. The DecodeME study has approval from North West - Liverpool Central Research Ethics Committee (21\/NW\/0169). DecodeME is registered in the Research Registry (identifying number 6395). More information on the study is available online (\n                      \n                      ). UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval, and researchers do not require separate ethical clearance and can operate under this RTB approval. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"JMS, SD, MP, DK, ARM, LMF, MS, MAS, and SG are employees of PrecisionLife Ltd. SG is a shareholder of PrecisionLife Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"733"}}